IDEAYA Biosciences IDYA
NASDAQ IDYA
$31.48 -0.55 (-1.72%)
As of: Nov 10, 2026 · 1:40 PM EST

IDEAYA Biosciences (IDYA) Share-based Compensation (2018 - 2026)

Updated

IDEAYA Biosciences (IDYA) recorded Share-based Compensation of $17.73 million in Q3 2026, up 45.1% from $12.22 million a year earlier and up 6.4% from the prior quarter.

Analysis

IDEAYA Biosciences (IDYA) Share-based Compensation (2018 - 2026) Analysis & Trends

On a TTM basis, IDEAYA Biosciences' Share-based Compensation came in at $60.72 million as of Sep 30, 2026, up 38.6% year-over-year; for FY2025, it came in at $46.12 million, up 32.7% from FY2024.

  • Annual Share-based Compensation has increased for eight straight years, with a five-year compound annual growth rate of 66.5% (FY2020 to FY2025).
  • Across earlier years, Share-based Compensation came in at $34.75 million in FY2024 (+87.9%), $18.49 million in FY2023 (+59.0%), $11.63 million in FY2022 (+41.2%) and $8.24 million in FY2021 (+128.2%).
  • The Q3 2026 figure is the highest quarterly Share-based Compensation in data going back to Q2 2018.
  • On a year-over-year basis, Share-based Compensation has increased for 30 consecutive quarters, with growth averaging 45.8% over the last eight quarters.
  • Across the past five years, year-over-year growth in Share-based Compensation ran from 21.9% in Q2 2025 to 105.7% in Q2 2024.
  • Per Business Quant, the preceding three quarters came in at $16.66 million (Q2 2026), $14.54 million (Q1 2026) and $11.79 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 200.00 Mn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 357.00 Mn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 160.00 Mn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 369.00 Mn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 128.00 Mn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 234.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 362.00 Mn
10 IDEAYA Biosciences 3.30 Bn 317.16 Mn - 17.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 17.73 Mn
Jun 30, 2026 16.66 Mn
Mar 31, 2026 14.54 Mn
Dec 31, 2025 11.79 Mn
Sep 30, 2025 12.22 Mn
Jun 30, 2025 11.87 Mn
Mar 31, 2025 10.24 Mn
Dec 31, 2024 9.49 Mn
Sep 30, 2024 9.22 Mn
Jun 30, 2024 9.73 Mn
Mar 31, 2024 6.31 Mn
Dec 31, 2023 4.80 Mn
Sep 30, 2023 5.30 Mn
Jun 30, 2023 4.73 Mn
Mar 31, 2023 3.66 Mn
Dec 31, 2022 2.98 Mn
Sep 30, 2022 3.00 Mn
Jun 30, 2022 3.04 Mn
Mar 31, 2022 2.61 Mn
Dec 31, 2021 2.06 Mn
API Access

IDEAYA Biosciences Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=IDYA&period=max&api_key=YOUR_API_KEY